Professor Adam Finn
Professor of Paediatrics | University of Bristol
Bristol, UNITED KINGDOM
Addressing infectious diseases and immunology with a core specialism in children's vaccines
Areas of Expertise (4)
Development of Vaccines
Immunology
Infectious Diseases
Vaccines
Biography
Professor Adam Finn is based in Bristol’s Children Vaccine Centre where his focus is on infectious diseases and immunology. His particular specialism is on vaccines for children: how they work and, in particular, how immunisation schemes can impact the transmission of infections.
Professor Finn leads the Bristol COVID Emergency Research Group, UNCOVER, which pools the combined expertise of researchers to understand and combat the many health and societal challenges raised by COVID-19. He also chairs the WHO European Technical Advisory Group of Experts on Immunisation and he is a member of the UK Department of Health’s Joint Committee on Vaccines and Immunisation.
Media
Publications:
Documents:
Photos:
Videos:
Audio/Podcasts:
Accomplishments (3)
Sparks Children’s Medical Research Charity, Excellence in Medical Research Award
2010
Clinical Excellence Award NHS, UK Dept Health (Gold)
2015
Bill Marshall Award, European Society for Paediatric Infectious Diseases
2009
Education (2)
University of Oxford: M.D., Clinical Medicine and Surgery 1983
University of Cambridge: M.Sc., Medical Sciences and History of Art 1980
Affiliations (3)
- Member, British Society for Immunology
- Member, British Inflammation Research Association
- Member, European Society for Paediatric Infectious Diseases
Links (2)
Media Appearances (5)
Do face masks work? Here's what the science says
The Telegraph online
2020-07-13
If you are confused about whether to wear a face mask, you're not alone. Even scientists cannot come to a consensus on whether they are a useful health intervention or could make the situation worse....
With 120 countries making masks compulsory in public, shouldn’t England?
The Guardian online
2020-07-11
Wearing masks is about protecting others, stressed Adam Finn, professor of paediatrics at Bristol University. “At least some transmission of the Covid-19 virus occurs when droplets generated by coughs and sneezes shoot across the space between you and someone else nearby. Wearing face coverings in crowded places will reduce the likelihood of that happening,” he said.
Scientists give cautious support to Johnson hints that face masks could be mandatory in shops
Evening Standard online
2020-07-11
Professor Adam Finn of the University of Bristol said: “The more efficient the face covering is at catching the droplets, the better it will work. “So if you are in a shop and everyone else is wearing a mask, you should feel safer than if they aren’t.”
Professor explains how vaccine trial works
SkyNews online
2020-04-23
Director of Bristol Children's Vaccine Centre, Professor Adam Finn, talks to Adam Boulton about the vaccine trials and testing.
Bristol start-up puts forward COVID-19 vaccine candidates
Insider Media online
2020-04-07
Professor Adam Finn, director of the Bristol Children’s Vaccine Centre at Bristol Medical School and co-ordinator of UNCOVER, said: "We believe the approach has a number of potential advantages, including avoidance of induction of disease-enhancing antibody responses, ready manufacture and thermostability, avoiding the need for cold chain storage.
Articles (5)
Impact of meningococcal B (4CMenB) vaccine on pharyngeal Neisseria meningitidis carriage density and persistence in adolescents
Clinical Infectious Diseases
2020 Higher density of Neisseria meningitidis carriage may be associated with transmission of the meningococcus. Our aim was to establish the impact of 4CMenB vaccine on N. meningitidis carriage density.
The jigsaw puzzle of chronic non-bacterial osteomyelitis: are anti-IL17 therapies the next piece?
Rheumatology
2020 Chronic non-bacterial osteomyelitis (CNO) is an inflammatory disorder of unknown aetiology characterized by painful sterile osteitis. It is also known as chronic recurrent multifocal osteomyelitis (CRMO). Bone inflammation is followed by hyperostosis and osteolytic lesions, most commonly in the clavicles, long bones and spine.
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia
The New England Journal of Medicine
2020 The meningococcal group B vaccine 4CMenB is a new, recombinant protein-based vaccine that is licensed to protect against invasive group B meningococcal disease. However, its role in preventing transmission and, therefore, inducing population (herd) protection is uncertain.
Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data
BMJ
2020 To assess the magnitude and duration of any hypothesised protective effect of household exposure to a child with varicella on the relative incidence of herpes zoster in adults.
Efficacy of pamidronate in children with chronic non-bacterial osteitis using whole body MRI as a marker of disease activity
Pediatric Rheumatology
2019 The medical records of children under the age of sixteen with a diagnosis of chronic non-bacterial osteitis between 2005 and 2018 were reviewed. All those who were treated with pamidronate were included and relevant data was collected. Response to therapy was determined based on the status of lesions on WB- MRI.
Social